findmyKOL
Clinical trialNCT00703105UnknownPhase 2Interventional

Ovarian Dendritic Cell Vaccine Trial

SponsorLoyola UniversityEnrollment36Ovarian Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center

    Maywood, Illinois, United States

    Amir Elmishad, MDCheryl Czerlanis, MDRonald Potkul, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2008
Primary completion
31 Jul 2021
Completion
31 Jul 2021
Last update posted
26 Apr 2021
Registered enrollment
36
Registry id
NCT00703105

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.